Literature DB >> 8658217

Endoscopic ultrasonography.

B J Pollack1, A Chak, M V Sivak.   

Abstract

Optimal treatment of gastric carcinoma requires accurate staging as there are marked differences in the prognosis of early and advanced gastric cancer which influence the decision for surgical resection versus nonsurgical palliation. Endoscopic ultrasonography (EUS), by virtue of its considerable accuracy, has become the method of choice for regional staging of gastric cancer. EUS is unique in its ability to image the gastric wall as a 5-layer structure that correlates with actual histological layers. Thus, tumor depth can be imaged very precisely. Peritumor inflammation is the most common cause for overstaging by EUS; difficulty in determining tumor involvement of, but not through, the subserosa is another important reason for inaccurate staging. EUS is able also to detect small lymph nodes in the perigastric region. Although assessment of malignancy in nodes can be difficult, ultrasound-guided fine needle aspiration cytology appears to be an accurate method to determine lymph node status. Surgery remains the standard treatment for gastric cancer, but new methods of endoscopic resection combined with high-frequency ultrasound may hold promise for future treatment of early gastric cancer. In addition to current radial and sector scanning instruments, recently introduced high-frequency ultrasound probes enhance the diagnostic possibilities of this technology.

Entities:  

Mesh:

Year:  1996        PMID: 8658217

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  13 in total

Review 1.  A systematic review and meta-analysis of the utility of EUS for preoperative staging for gastric cancer.

Authors:  Roberta Cardoso; Natalie Coburn; Rajini Seevaratnam; Rinku Sutradhar; Laercio Gomes Lourenco; Alyson Mahar; Calvin Law; Elaine Yong; Jill Tinmouth
Journal:  Gastric Cancer       Date:  2012-01-12       Impact factor: 7.370

Review 2.  How good is endoscopic ultrasound for TNM staging of gastric cancers? A meta-analysis and systematic review.

Authors:  Srinivas-Reddy Puli; Jyotsna Batapati Krishna Reddy; Matthew L Bechtold; Mainor R Antillon; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 3.  Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer?

Authors:  Sung Wook Hwang; Dong Ho Lee
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 4.  The utility of MRI for pre-operative T and N staging of gastric carcinoma: a systematic review and meta-analysis.

Authors:  Z Huang; D H Xie; L Guo; C H Hu; X Fang; Q Meng; X X Ping; Z W Lu
Journal:  Br J Radiol       Date:  2015-03-19       Impact factor: 3.039

Review 5.  Updates on esophageal and gastric cancers.

Authors:  Amy Gallo; Charles Cha
Journal:  World J Gastroenterol       Date:  2006-05-28       Impact factor: 5.742

6.  Gastric adenocarcinoma: reduction of perioperative mortality by avoidance of nontherapeutic laparotomy.

Authors:  Brian R Smith; Bruce E Stabile
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

Review 7.  Gastric carcinoma.

Authors:  Alexandria T Phan; Jaffer A Ajani
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

8.  Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer.

Authors:  Xiaoyuan Chu; Zhong-Fa Yang
Journal:  World J Surg Oncol       Date:  2015-06-01       Impact factor: 2.754

9.  Lymph node metastasis of gastric cancer.

Authors:  Tomonori Akagi; Norio Shiraishi; Seigo Kitano
Journal:  Cancers (Basel)       Date:  2011-04-26       Impact factor: 6.639

10.  Saudi Oncology Society clinical management guideline series. Gastric cancer 2014.

Authors:  Magdy S Kandil; Shouki N Bazarbashi; Mohammed M Rahal; Ahmed S Al-Shehri; Ali M Alzahrani; Ali H Aljubran; Jamal E Zekri; Ashwaq A Al Olayan; Abdullah A Alsharm; Nizar M Yamani; Ibrahim S Alomary; Mosa A Fagih
Journal:  Saudi Med J       Date:  2014-12       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.